Radotinib is an oral tyrosine kinase inhibitor used primarily for the treatment of specific malignancies such as non-small cell lung cancer by blocking the kinases responsible for tumor progression. To… Read more
Radotinib is an oral tyrosine kinase inhibitor used primarily for the treatment of specific malignancies such as non-small cell lung cancer by blocking the kinases responsible for tumor progression. To support critical analytical workflows, this category includes the parent drug alongside high-quality stable isotope labelled compounds like Radotinib-d6. Pharmaceutical laboratories rely on these reference standards for accurate impurity profiling, method validation, and rigorous quality control testing. By incorporating deuterated analogues, researchers can utilize distinct mass properties as internal standards in liquid chromatography-mass spectrometry (LC-MS) assays to achieve reliable quantification of metabolites and ensure compliance with regulatory standards. Accessing these essential chemical tools facilitates the development and monitoring of therapeutic agents, helping laboratories maintain precision throughout the drug lifecycle and complex bioanalytical studies.